Trials / Active Not Recruiting
Active Not RecruitingNCT05719116
A Combined Aerobic and Resistance Training Program for Adults With Psychotic Disorders
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Solli Distriktspsykiatriske Senter · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is a feasibility study of a combined high intensity aerobic and strenght exercise program for persons with psychotic disorders. The feasibility of the protocol will be investigated, in addition to the participants subjective experience with the participation.
Detailed description
The aim of this study is to investigate the feasibility of a 16 week physical exercise intervention combining strenght and aerobic training in group for patients with psychotic disorders. In addition, the feasibility of the test protocol and participants subjective experience with the intervention will be investigated. Research shows positive effects of physical exercise for patients with psychotic disorders regarding maximal aerob training, maximal muscle strength, physical, cognitive and social functioning, and symptom levels. Effects and the degree of feasibility of physical exercise for patients with psychotic disorders are amplified by regarding their preferences and needs, and if they experience support and guidance during the intervention. Earlier studies have focused mostly on either strength og endurance training, or combined interventions of moderate intensity. We now want to investigate the feasibility of an invidually adjusted combined program of high intensity. After the intervention, participants will be interviewed about their experience with participating.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Physical exercise | The physical exercise will be aerobic and strength training. The sessions will last app. 1 hour. |
Timeline
- Start date
- 2022-11-23
- Primary completion
- 2026-12-31
- Completion
- 2028-12-31
- First posted
- 2023-02-08
- Last updated
- 2025-09-24
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT05719116. Inclusion in this directory is not an endorsement.